A detailed history of Principal Financial Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Principal Financial Group Inc holds 4,690,312 shares of ABT stock, worth $527 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
4,690,312
Previous 4,782,027 1.92%
Holding current value
$527 Million
Previous $544 Million 10.33%
% of portfolio
0.3%
Previous 0.33%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$100.73 - $112.44 $9.24 Million - $10.3 Million
-91,715 Reduced 1.92%
4,690,312 $487 Million
Q1 2024

Apr 29, 2024

BUY
$109.52 - $120.96 $4.17 Million - $4.61 Million
38,117 Added 0.8%
4,782,027 $544 Million
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $10.9 Million - $13.4 Million
-120,988 Reduced 2.49%
4,743,910 $522 Million
Q3 2023

Nov 02, 2023

BUY
$95.53 - $114.62 $19.4 Million - $23.2 Million
202,590 Added 4.35%
4,864,898 $471 Million
Q2 2023

Aug 07, 2023

SELL
$100.78 - $112.29 $31 Million - $34.6 Million
-307,827 Reduced 6.19%
4,662,308 $508 Million
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $5.52 Million - $6.5 Million
56,996 Added 1.16%
4,970,135 $503 Million
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $8.7 Million - $10.2 Million
-91,471 Reduced 1.83%
4,913,139 $540 Million
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $14.9 Million - $17.2 Million
-153,721 Reduced 2.98%
5,004,610 $484 Million
Q2 2022

Aug 10, 2022

SELL
$102.07 - $123.37 $38.3 Million - $46.3 Million
-375,105 Reduced 6.78%
5,158,331 $560 Million
Q1 2022

May 09, 2022

SELL
$114.02 - $139.04 $21.1 Million - $25.7 Million
-185,045 Reduced 3.24%
5,533,436 $655 Million
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $23.2 Million - $28.4 Million
201,067 Added 3.64%
5,718,481 $804 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $27.4 Million - $30.3 Million
234,707 Added 4.44%
5,517,414 $652 Million
Q2 2021

Aug 10, 2021

BUY
$105.79 - $124.53 $6.62 Million - $7.8 Million
62,606 Added 1.2%
5,282,707 $612 Million
Q1 2021

May 10, 2021

SELL
$108.84 - $128.23 $15 Million - $17.7 Million
-138,184 Reduced 2.58%
5,220,101 $626 Million
Q4 2020

Feb 23, 2021

SELL
$105.0 - $114.42 $1,575 - $1,716
-15 Reduced -0.0%
5,358,285 $587 Million
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $9.17 Million - $9.99 Million
87,343 Added 1.66%
5,358,300 $587 Million
Q3 2020

Nov 06, 2020

SELL
$91.64 - $111.29 $21.3 Million - $25.9 Million
-232,441 Reduced 4.22%
5,270,957 $574 Million
Q2 2020

Aug 05, 2020

BUY
$76.57 - $98.0 $42.6 Million - $54.5 Million
556,192 Added 11.24%
5,503,398 $503 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $9.14 Million - $13.4 Million
145,525 Added 3.03%
4,947,206 $390 Million
Q4 2019

Feb 05, 2020

BUY
$78.51 - $87.4 $208,444 - $232,047
2,655 Added 0.06%
4,801,681 $417 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $21.6 Million - $23.5 Million
-264,344 Reduced 5.22%
4,799,026 $402 Million
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $1.75 Million - $2.04 Million
-24,058 Reduced 0.47%
5,063,370 $426 Million
Q1 2019

May 10, 2019

SELL
$66.22 - $80.06 $13.2 Million - $16 Million
-199,909 Reduced 3.78%
5,087,428 $407 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $8.32 Million - $9.42 Million
126,874 Added 2.46%
5,287,337 $382 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $3.86 Million - $4.66 Million
63,552 Added 1.25%
5,160,463 $379 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $2.48 Million - $2.74 Million
-43,104 Reduced 0.84%
5,096,911 $0
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $11.9 Million - $13.4 Million
211,233 Added 4.29%
5,140,015 $308 Million
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $26.1 Million - $28 Million
486,933 Added 10.96%
4,928,782 $281 Million
Q3 2017

Nov 02, 2017

BUY
$48.06 - $53.64 $213 Million - $238 Million
4,441,849
4,441,849 $237 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.